IS8422A - Bensímídasólafleiður, efnablöndur sem innihalda þær, framleiðsla þeirra og notkun þeirra - Google Patents

Bensímídasólafleiður, efnablöndur sem innihalda þær, framleiðsla þeirra og notkun þeirra

Info

Publication number: IS8422A
Authority: IS; Iceland
Prior art keywords: preparation; preparations containing; benzimidazole derivatives; benzimidazole; derivatives
Prior art date: 2003-09-26

Application number

IS8422A

Other languages

English (en)

Inventor

Liu Ziping

Pagé Daniel

Walpole Christopher

Yang Hua

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-09-26

Filing date

2006-04-21

Publication date

2006-04-21

2006-04-21 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2006-04-21 Publication of IS8422A publication Critical patent/IS8422A/is

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/08—Radicals containing only hydrogen and carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/14—Radicals substituted by nitrogen atoms

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Psychology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

IS8422A 2003-09-26 2006-04-21 Bensímídasólafleiður, efnablöndur sem innihalda þær, framleiðsla þeirra og notkun þeirra IS8422A (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE0302573A SE0302573D0 (sv)	2003-09-26	2003-09-26	Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
PCT/GB2004/004124 WO2005030732A1 (en)	2003-09-26	2004-09-24	Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof

Publications (1)

Publication Number	Publication Date
IS8422A true IS8422A (is)	2006-04-21

Family

ID=29246982

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS8422A IS8422A (is)	2003-09-26	2006-04-21	Bensímídasólafleiður, efnablöndur sem innihalda þær, framleiðsla þeirra og notkun þeirra

Country Status (33)

Country	Link
US (1)	US8633235B2 (is)
EP (1)	EP1670769B1 (is)
JP (1)	JP4896721B2 (is)
KR (1)	KR101170184B1 (is)
CN (2)	CN1886379A (is)
AR (1)	AR045819A1 (is)
AT (1)	ATE430135T1 (is)
AU (1)	AU2004276062B2 (is)
BR (1)	BRPI0414780B8 (is)
CA (1)	CA2539738C (is)
CO (1)	CO5680443A2 (is)
CY (1)	CY1110332T1 (is)
DE (1)	DE602004020907D1 (is)
DK (1)	DK1670769T3 (is)
ES (1)	ES2324669T3 (is)
HR (1)	HRP20090388T1 (is)
IL (1)	IL174215A0 (is)
IS (1)	IS8422A (is)
MX (1)	MXPA06003197A (is)
MY (1)	MY140630A (is)
NO (1)	NO20061839L (is)
NZ (1)	NZ545736A (is)
PL (1)	PL1670769T3 (is)
PT (1)	PT1670769E (is)
RU (1)	RU2346938C2 (is)
SA (1)	SA04250310B1 (is)
SE (1)	SE0302573D0 (is)
SI (1)	SI1670769T1 (is)
TW (1)	TW200521117A (is)
UA (1)	UA86776C2 (is)
UY (1)	UY28536A1 (is)
WO (1)	WO2005030732A1 (is)
ZA (3)	ZA200602446B (is)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE375349T1 (de)	2002-08-02	2007-10-15	Merck & Co Inc	Substituierte furo(2,3-b)pyridin derivate
SE0302573D0 (sv)	2003-09-26	2003-09-26	Astrazeneca Ab	Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
RU2374234C2 (ru)	2004-09-24	2009-11-27	Астразенека Аб	Бензимидазольные производные, содержащие их композиции, их получение и применение
CA2582507A1 (en) *	2004-09-24	2006-03-30	Astrazeneca Ab	Compounds, compositions containing them, preparation thereof and uses thereof iii
CN101031563A (zh) *	2004-09-24	2007-09-05	阿斯利康(瑞典)有限公司	苯并咪唑衍生物、含有它们的组合物、其制备方法和用途
AU2005287427B2 (en) *	2004-09-24	2009-03-26	Astrazeneca Ab	Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof I
DE602005011844D1 (de)	2004-11-02	2009-01-29	Pfizer	Sulfonylbenzimidazolderivate
EP1912930A4 (en) *	2005-07-29	2010-04-14	Astrazeneca Ab	PROCESS FOR PREPARING GEMINAL ((DIFLUORCYCLOALKYL) METHYL) AMINE
TW200745049A (en) *	2006-03-23	2007-12-16	Astrazeneca Ab	New crystalline forms
TW200808769A (en) *	2006-04-18	2008-02-16	Astrazeneca Ab	Therapeutic compounds
US20080139846A1 (en) *	2006-09-01	2008-06-12	Astrazeneca Ab	New Process 298
WO2008032764A1 (en) *	2006-09-13	2008-03-20	Kyowa Hakko Kirin Co., Ltd.	Fused heterocyclic derivative
US20110086853A1 (en) *	2009-10-08	2011-04-14	William Brown	Therapeutic Compounds
RU2414899C1 (ru) *	2009-12-29	2011-03-27	Аверин Константин Михайлович	Средства для лечения рассеянного склероза
RU2454234C1 (ru) *	2011-03-16	2012-06-27	Константин Михайлович Аверин	Соли 1,3-диэтилбензимидазолия - иммуностимулирующие средства и фармацевтические композиции на их основе
JP2015529692A (ja) *	2012-06-13	2015-10-08	サイテク・テクノロジー・コーポレーシヨン	置換クロマン化合物を含む安定剤組成物および使用方法
SG11201408254UA (en)	2012-06-26	2015-01-29	Bayer Pharma AG	N-[4-(Quinolin-4-yloxy)cyclohexyl(methyl)](hetero)arylcarboxamides as androgen receptor antagonists, production and use thereof as medicinal products
WO2019170543A1 (en)	2018-03-07	2019-09-12	Bayer Aktiengesellschaft	Identification and use of erk5 inhibitors
WO2020234103A1 (en)	2019-05-21	2020-11-26	Bayer Aktiengesellschaft	Identification and use of kras inhibitors
CN112010789A (zh) *	2019-05-31	2020-12-01	中国科学院上海药物研究所	乙烯基磺酰胺或乙烯基酰胺类化合物及其制备方法和用途
GB202019335D0 (en) *	2020-12-08	2021-01-20	Artelo Biosciences Ltd	Pharmaceutical compositions
US20250171451A1 (en) *	2022-03-04	2025-05-29	Samjin Pharmaceutical Co., Ltd.	Novel heterocyclic compound and pharmaceutical composition comprising same

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR1604908A (en)	1965-06-24	1971-05-15		Substd benzimidazoles - with anthelmintic,fungicidal activity and some with antiviral and antibacterial activity
FR5354M (is)	1965-09-10	1967-09-11
US5387600A (en)	1992-07-30	1995-02-07	Fuji Photo Film Co., Ltd.	Treating arteriosclerosis using benzimidazole compositions
DE4237597A1 (de)	1992-11-06	1994-05-11	Bayer Ag	Substituierte Benzimidazole
DE4237557A1 (de)	1992-11-06	1994-05-11	Bayer Ag	Substituierte Benzimidazole
DE4237617A1 (de)	1992-11-06	1994-05-11	Bayer Ag	Verwendung von substituierten Benzimidazolen
AU722514B2 (en)	1995-12-28	2000-08-03	Fujisawa Pharmaceutical Co., Ltd.	Benzimidazole derivatives
TW453999B (en) *	1997-06-27	2001-09-11	Fujisawa Pharmaceutical Co	Benzimidazole derivatives
US6348032B1 (en)	1998-11-23	2002-02-19	Cell Pathways, Inc.	Method of inhibiting neoplastic cells with benzimidazole derivatives
US6534535B1 (en)	1999-08-12	2003-03-18	Millennium Pharmaceuticals, Inc.	Inhibitors of factor Xa
US6844367B1 (en)	1999-09-17	2005-01-18	Millennium Pharmaceuticals, Inc.	Benzamides and related inhibitors of factor Xa
HUP0203954A2 (hu)	1999-09-17	2003-03-28	Millennium Pharmaceuticals, Inc.	Xa faktor inhibitorok
US6632815B2 (en)	1999-09-17	2003-10-14	Millennium Pharmaceuticals, Inc.	Inhibitors of factor Xa
US6720317B1 (en)	1999-09-17	2004-04-13	Millennium Pharmaceuticals, Inc.	Inhibitors of factor Xa
CA2396227C (en) *	2000-01-14	2012-03-20	Schering Aktiengesellschaft	1,2-diaryl benzimidazoles for treating illnesses associated with a microglia activation
US7115645B2 (en)	2000-01-14	2006-10-03	Schering Aktiengesellschaft	1,2 diarylbenzimidazoles and their pharmaceutical use
US7329679B2 (en) *	2000-01-27	2008-02-12	Schering Aktiengesellschaft	1,2 Diarylbenzimidazoles and their pharmaceutical use
WO2001064643A2 (en)	2000-02-29	2001-09-07	Cor Therapeutics, Inc.	BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa
WO2002000651A2 (en)	2000-06-27	2002-01-03	Bristol-Myers Squibb Pharma Company	Factor xa inhibitors
WO2002046168A1 (en)	2000-12-07	2002-06-13	Astrazeneca Ab	Therapeutic benzimidazole compounds
SE0101387D0 (sv)	2001-04-20	2001-04-20	Astrazeneca Ab	Novel compounds
JPWO2002100833A1 (ja)	2001-06-12	2004-09-24	住友製薬株式会社	Ｒｈｏキナーゼ阻害剤
TW200505902A (en)	2003-03-20	2005-02-16	Schering Corp	Cannabinoid receptor ligands
SE0301699D0 (sv)	2003-06-10	2003-06-10	Astrazeneca Ab	Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0301701D0 (sv)	2003-06-10	2003-06-10	Astrazeneca Ab	Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
US20050026968A1 (en)	2003-07-14	2005-02-03	University Of Tennessee Research Foundation	Heterocyclic amides with anti-tuberculosis activity
WO2005021547A2 (en)	2003-08-28	2005-03-10	Pharmaxis Pty Ltd.	Heterocyclic cannabinoid cb2 receptor antagonists
SE0302573D0 (sv)	2003-09-26	2003-09-26	Astrazeneca Ab	Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0302572D0 (sv)	2003-09-26	2003-09-26	Astrazeneca Ab	Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0302570D0 (sv)	2003-09-26	2003-09-26	Astrazeneca Ab	Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0302571D0 (sv)	2003-09-26	2003-09-26	Astrazeneca Ab	Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
WO2005113542A2 (en)	2004-05-20	2005-12-01	Elan Pharmaceuticals, Inc.	N-cyclic sulfonamido inhibitors of gamma secretase
US20060135773A1 (en)	2004-06-17	2006-06-22	Semple Joseph E	Trisubstituted nitrogen modulators of tyrosine phosphatases
JP4703649B2 (ja)	2004-07-30	2011-06-15	エグゼリクシス，インコーポレイテッド	薬学的因子としてのピロール誘導体
US20060052421A1 (en)	2004-09-09	2006-03-09	Eastman Kodak Company	Conjugation agent
CA2582507A1 (en)	2004-09-24	2006-03-30	Astrazeneca Ab	Compounds, compositions containing them, preparation thereof and uses thereof iii
AU2005287427B2 (en)	2004-09-24	2009-03-26	Astrazeneca Ab	Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof I
JP2008514591A (ja)	2004-09-24	2008-05-08	アストラゼネカ・アクチエボラーグ	ベンゾイミダゾール誘導体及びカンナビノイド受容体リガンドとしてのその使用
WO2006033628A1 (en)	2004-09-24	2006-03-30	Astrazeneca Ab	Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
RU2374234C2 (ru) *	2004-09-24	2009-11-27	Астразенека Аб	Бензимидазольные производные, содержащие их композиции, их получение и применение
JP2008514594A (ja)	2004-09-24	2008-05-08	アストラゼネカ・アクチエボラーグ	ベンゾイミダゾール誘導体及びカンナビノイド受容体リガンドとしてのその使用ｉ
JP2008514589A (ja)	2004-09-24	2008-05-08	アストラゼネカ・アクチエボラーグ	化合物、それらを含有する組成物、それらの製造及びそれらの使用ｉｉｉｉ
AU2005287429A1 (en)	2004-09-24	2006-03-30	Astrazeneca Ab	Compounds, compositions containing them, preparations thereof and uses thereof II
DE602005011844D1 (de)	2004-11-02	2009-01-29	Pfizer	Sulfonylbenzimidazolderivate
WO2006078941A2 (en)	2005-01-20	2006-07-27	Sirtris Pharmaceuticals, Inc.	Novel sirtuin activating compounds and methods of use thereof
TW200745049A (en)	2006-03-23	2007-12-16	Astrazeneca Ab	New crystalline forms
TW200808769A (en)	2006-04-18	2008-02-16	Astrazeneca Ab	Therapeutic compounds
TW200808772A (en)	2006-06-13	2008-02-16	Astrazeneca Ab	Therapeutic compounds

2003
- 2003-09-26 SE SE0302573A patent/SE0302573D0/xx unknown
2004
- 2004-09-24 CA CA2539738A patent/CA2539738C/en not_active Expired - Lifetime
- 2004-09-24 MY MYPI20043910A patent/MY140630A/en unknown
- 2004-09-24 CN CNA2004800350086A patent/CN1886379A/zh active Pending
- 2004-09-24 DE DE602004020907T patent/DE602004020907D1/de not_active Expired - Lifetime
- 2004-09-24 MX MXPA06003197A patent/MXPA06003197A/es active IP Right Grant
- 2004-09-24 TW TW093129150A patent/TW200521117A/zh unknown
- 2004-09-24 WO PCT/GB2004/004124 patent/WO2005030732A1/en not_active Ceased
- 2004-09-24 SI SI200431166T patent/SI1670769T1/sl unknown
- 2004-09-24 UY UY28536A patent/UY28536A1/es unknown
- 2004-09-24 JP JP2006527490A patent/JP4896721B2/ja not_active Expired - Lifetime
- 2004-09-24 CN CN2010105277900A patent/CN102010373A/zh active Pending
- 2004-09-24 BR BRPI0414780A patent/BRPI0414780B8/pt not_active IP Right Cessation
- 2004-09-24 US US10/573,054 patent/US8633235B2/en active Active
- 2004-09-24 AU AU2004276062A patent/AU2004276062B2/en not_active Expired
- 2004-09-24 PT PT04768667T patent/PT1670769E/pt unknown
- 2004-09-24 AT AT04768667T patent/ATE430135T1/de active
- 2004-09-24 KR KR1020067005825A patent/KR101170184B1/ko not_active Expired - Lifetime
- 2004-09-24 ES ES04768667T patent/ES2324669T3/es not_active Expired - Lifetime
- 2004-09-24 UA UAA200602693A patent/UA86776C2/ru unknown
- 2004-09-24 AR ARP040103467A patent/AR045819A1/es not_active Application Discontinuation
- 2004-09-24 HR HR20090388T patent/HRP20090388T1/xx unknown
- 2004-09-24 PL PL04768667T patent/PL1670769T3/pl unknown
- 2004-09-24 EP EP04768667A patent/EP1670769B1/en not_active Expired - Lifetime
- 2004-09-24 DK DK04768667T patent/DK1670769T3/da active
- 2004-09-24 RU RU2006113371/04A patent/RU2346938C2/ru active
- 2004-09-24 NZ NZ545736A patent/NZ545736A/en unknown
- 2004-09-26 SA SA04250310A patent/SA04250310B1/ar unknown
2006
- 2006-03-09 IL IL174215A patent/IL174215A0/en unknown
- 2006-03-22 CO CO06028452A patent/CO5680443A2/es not_active Application Discontinuation
- 2006-03-24 ZA ZA200602446A patent/ZA200602446B/en unknown
- 2006-04-21 IS IS8422A patent/IS8422A/is unknown
- 2006-04-26 NO NO20061839A patent/NO20061839L/no not_active Application Discontinuation
2007
- 2007-03-13 ZA ZA200702131A patent/ZA200702131B/xx unknown
- 2007-03-16 ZA ZA200702226A patent/ZA200702226B/xx unknown
2009
- 2009-07-08 CY CY20091100725T patent/CY1110332T1/el unknown

Also Published As

Publication number	Publication date
KR101170184B1 (ko)	2012-07-31
EP1670769A1 (en)	2006-06-21
CN102010373A (zh)	2011-04-13
CO5680443A2 (es)	2006-09-29
AR045819A1 (es)	2005-11-16
SI1670769T1 (sl)	2009-10-31
JP2007506721A (ja)	2007-03-22
CY1110332T1 (el)	2015-01-14
CN1886379A (zh)	2006-12-27
SE0302573D0 (sv)	2003-09-26
ZA200702131B (en)	2008-08-27
TW200521117A (en)	2005-07-01
PT1670769E (pt)	2009-07-09
RU2006113371A (ru)	2007-11-10
NO20061839L (no)	2006-06-26
US8633235B2 (en)	2014-01-21
ZA200602446B (en)	2007-09-26
BRPI0414780A (pt)	2006-11-21
ATE430135T1 (de)	2009-05-15
US20080207612A1 (en)	2008-08-28
HRP20090388T1 (hr)	2009-08-31
DK1670769T3 (da)	2009-08-10
UA86776C2 (ru)	2009-05-25
ZA200702226B (en)	2009-01-28
WO2005030732A1 (en)	2005-04-07
UY28536A1 (es)	2005-04-29
ES2324669T3 (es)	2009-08-12
PL1670769T3 (pl)	2009-09-30
DE602004020907D1 (de)	2009-06-10
SA04250310B1 (ar)	2009-01-19
EP1670769B1 (en)	2009-04-29
KR20070001052A (ko)	2007-01-03
AU2004276062B2 (en)	2008-05-22
IL174215A0 (en)	2006-08-01
MY140630A (en)	2010-01-15
NZ545736A (en)	2009-11-27
BRPI0414780B8 (pt)	2021-05-25
JP4896721B2 (ja)	2012-03-14
CA2539738A1 (en)	2005-04-07
MXPA06003197A (es)	2006-06-23
HK1089436A1 (en)	2006-12-01
RU2346938C2 (ru)	2009-02-20
CA2539738C (en)	2011-11-22
BRPI0414780B1 (pt)	2018-10-23
AU2004276062A1 (en)	2005-04-07

Publication	Publication Date	Title
IS8422A (is)	2006-04-21	Bensímídasólafleiður, efnablöndur sem innihalda þær, framleiðsla þeirra og notkun þeirra
DK1673349T3 (da)	2010-10-25	Benzimidazolderivater: fremstilling og farmaceutiske anvendelser
IS6661A (is)	2002-12-19	Bensimídasólafleiður, framleiðsla þeirra og meðferðarleg notkun
IS8219A (is)	2006-01-04	Bensímídasólafleiður, efnablöndur sem innihalda þær, framleiðsla þeirra og notkun
IS7079A (is)	2003-12-15	Fenýlsúlfónýl-1,3-díhýdró-2H-indól-2-ón afleiður,framleiðsla þeirra og notkun í meðferðarskyni
IS2458B (is)	2008-11-15	Indólín-2-ón afleiður, framleiðsla og notkun þeirra sem mjaltavaka (ocytocin) viðtakabindlar
DK1511734T3 (da)	2010-08-02	Forbindelser, præparater og fremgangsmåder
IS7491A (is)	2004-10-06	Benzoxazínon-afleidd efnasambönd, framleiðsla þeirra og notkun sem lyf
DK1095025T3 (da)	2003-04-07	Benzimidazoler, deres fremstilling og deres anvendelse som lægemidler
DK1590321T3 (da)	2010-08-09	Arylalkylcarbamat-derivater, fremstilling og terapeutisk anvendelse deraf
DK1513836T3 (da)	2006-09-11	Piperazinylacylpiperidinderivater, fremstilling og terapeutisk anvendelse heraf
IS8220A (is)	2006-01-04	Bensímídasólafleiður, blöndur sem innihalda þær, framleiðsla þeirra og notkun
DK1334106T3 (da)	2006-09-18	Imidazolderivater, fremstillingsmetoder deraf og anvendelse deraf
DK1417189T3 (da)	2006-05-08	Acylaminothiazolderivater, fremstilling og terapeutisk anvendelse heraf
DK1556382T3 (da)	2008-10-06	3-Phenylpyridoindolderivater, fremstilling og terapeutisk anvendelse deraf
IS7798A (is)	2005-04-11	Efnasambönd, lyfjablöndur og aðferðir
NO20053809D0 (no)	2005-08-12	Diarylmetylindenpiperidinderivater,fremgangsmate for fremstilling derav, og anvendelse derav
SI1673349T1 (sl)	2010-10-29	Derivati benzimidazola: priprava in farmacevtske uporabe
NO20033120D0 (no)	2003-07-08	2-arylimino-2,3-dihydrotiazolderivater, fremgangsmater for fremstilling derav og terapeutisk anvendelse derav
DK1773829T3 (da)	2009-04-20	Aminotropanderivater, fremstilling og terapeutiske anvendelser heraf
NO20053805D0 (no)	2005-08-12	Diarylmetylindenpiperidinderivater, framgangsmate for fremstilling derav, og anvendelse derav
DK1791872T3 (da)	2009-05-04	Biotinylerede hexadecasaccharider, farmaceutiske præparater og anvendelse heraf
NO20055142D0 (no)	2005-11-02	Diarylmetylidenpiperidinderivater, fremstillinger og anvendelser derav
DK1781631T3 (da)	2012-05-14	Diarylmethylpiperazinderivater, præparater dermed og anvendelser deraf
DK1309594T3 (da)	2005-04-25	Benzimidazolderivater, fremstilling heraf og terapeutisk anvendelse heraf